Bioaffinity Technologies, Inc. (BIAF) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Bioaffinity Technologies, Inc., a Delaware corporation, on October 10, 2023. The company is an emerging growth company with its principal executive offices in San Antonio, Texas. Its common stock and tradeable warrants trade on The Nasdaq Stock Market LLC under the symbols BIAF and BIAFW, respectively.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves as a disclosure of upcoming investor communications rather than a financial results announcement.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing discloses the company's intent to conduct investor presentations over the coming weeks.
Guidance, Outlook, and Management Commentary
- Investor Presentations: The company intends to discuss an investor presentation (furnished as Exhibit 99.1) and will present at an upcoming conference.
- Forward-Looking Statements: The investor presentation contains "safe harbor" language indicating that certain statements are forward-looking rather than historical.
- Legal Disclaimer: Information in this Item 7.01, the investor presentation, and the accompanying press release (Exhibit 99.2) is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into other SEC filings.
Key Facts for Investor Verification
- Verify the content of the investor presentation (Exhibit 99.1) and press release (Exhibit 99.2) attached to this filing for specific business updates.
- Confirm the dates and details of the upcoming investor conference mentioned in the press release.
- Note that the company is classified as an emerging growth company, which may impact financial reporting requirements.
- Review the "safe harbor" language in the presentation to understand the limitations of forward-looking statements.